Results 51 to 60 of about 8,469 (207)

Spectrum of Pituitary disorders: A retrospective study from Basrah, Iraq [version 2; referees: 2 approved]

open access: yesF1000Research, 2018
Background: Pituitary disorders spectrum includes a wide variety of diseases.This study aimed at a comprehensive description of such disorders for patients from  Faiha Specialized Diabetes, Endocrine and Metabolism Center (FDEMC) in Basrah (Southern Iraq)
Abbas Ali Mansour   +11 more
doaj   +1 more source

Vertebral Metastasis With Syringomyelia Secondary to Breast Adenocarcinoma: A Case Report and Literature Review

open access: yesClinical Case Reports, Volume 13, Issue 7, July 2025.
ABSTRACT Syringomyelia has several possible causes, commonly including Chiari malformation, spinal cord tumors and injuries, and damage caused by lesions around the spinal cord. A 34‐year‐old female was diagnosed with primary breast cancer and vertebral metastasis and was initiated on an extensive regimen of chemotherapy and radiotherapy.
Ahmed Reda Abdelhalim   +3 more
wiley   +1 more source

Pathogenesis, diagnosis and current treatment of prolactinoma: a review of the literature

open access: yesQuality in Sport
: Prolactinoma is a benign tumor of the pituitary gland that leads to the overproduction of prolactin. It is the most common type of pituitary adenoma, accounting for approximately 50% of all pituitary tumors. The clinical presentation of prolactinoma
Monika Szyszka   +6 more
doaj   +1 more source

Predictors of Mortality in Patients With Multiple Endocrine Neoplasia Type 1

open access: yesClinical Endocrinology, Volume 103, Issue 1, Page 50-56, July 2025.
SUMMARY Objective Multiple Endocrine Neoplasia Type 1 (MEN 1) is an autosomal dominant disease predisposing to hyperplasia and neoplasia in diverse endocrine tissues. Patients typically present with endocrine abnormalities before the age of 30 years and have reduced life expectancy.
Jasmine J. Zhu, John R Burgess
wiley   +1 more source

Anti-EGFL7 antibodies inhibit rat prolactinoma MMQ cells proliferation and PRL secretion

open access: yesOpen Chemistry, 2018
Prolactinoma is the most frequently diagnosed pituitary tumors. Dopamine agonists (DAs) are recognized as first-line therapy; however, approximately 10% patients will develop resistance to DAs therapy.
Liu Qian   +5 more
doaj   +1 more source

Hypersomatotropism and Hypercortisolism Caused by a Plurihormonal Pituitary Adenoma in a Dog

open access: yesJournal of Veterinary Internal Medicine, Volume 39, Issue 4, July/August 2025.
ABSTRACT A 12‐year‐old, male Labrador Retriever was presented because of polyuria, polydipsia, polyphagia, joint pain, and physical features consistent with acromegaly. Circulating insulin‐like growth factor‐1 (IGF‐1) concentration was increased (> 1000 ng/mL; reference interval [RI], 42–449), suggestive of hypersomatotropism.
Elber A. Soler Arias   +3 more
wiley   +1 more source

Cancer incidence and stage at diagnosis in children and adolescents in the Community of Madrid, 2015–2018

open access: yesPaediatric and Perinatal Epidemiology, Volume 39, Issue 5, Page 445-455, July 2025.
Abstract Background Cancer is the leading cause of death in children aged 1–14 and the second in 15‐19‐year‐old adolescents in Spain. The Paediatric Population‐Based Cancer Registry of the Community of Madrid was created to monitor its incidence and survival.
Raquel López‐González   +5 more
wiley   +1 more source

Advances in the Treatment of Prolactinomas [PDF]

open access: yesEndocrine Reviews, 2006
Prolactinomas account for approximately 40% of all pituitary adenomas and are an important cause of hypogonadism and infertility. The ultimate goal of therapy for prolactinomas is restoration or achievement of eugonadism through the normalization of hyperprolactinemia and control of tumor mass. Medical therapy with dopamine agonists is highly effective
M. P. Gillam   +3 more
openaire   +4 more sources

Revisiting Late‐Onset Bipolar Disorder Associated With Pituitary Adenoma: A Cross‐Sectional, Multidisciplinary, Case‐Based Analysis

open access: yesBrain and Behavior, Volume 15, Issue 6, June 2025.
Surveying 300 neurologists, psychiatrists, and family physicians, this study demonstrates discipline‐specific strengths‐imaging (neurology), diagnosis (psychiatry), and pharmacological follow‐up (family medicine)‐yet persistent gaps in holistic care of late‐onset bipolar disorder in elders.
Yagmur Sever Fidan   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy